Alzheimer's Disease was first identified more than 100 years ago. Yet despite this century-spanning awareness by medical communities across the globe, the precise physiologic mechanisms triggering the development of this disease are still unknown. Advocacy groups such as the Alzheimer's Association play a critical role in advancing new science and supporting those affected both directly and indirectly by this devastating illness. Joining host Paul Rokuskie to speak on behalf of the Alzheimer's Association's latest advocacy initiatives is Claire Day, Vice President of Constituent Services of the AA's Delaware Valley Chapter.
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Advocacy Updates from the Alzheimer's Association
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Presenters
Recommended
Details
Presenters
Comments
Recommended
Overview
Alzheimer's Disease was first identified more than 100 years ago. Yet despite this century-spanning awareness by medical communities across the globe, the precise physiologic mechanisms triggering the development of this disease are still unknown. Advocacy groups such as the Alzheimer's Association play a critical role in advancing new science and supporting those affected both directly and indirectly by this devastating illness. Joining host Paul Rokuskie to speak on behalf of the Alzheimer's Association's latest advocacy initiatives is Claire Day, Vice President of Constituent Services of the AA's Delaware Valley Chapter.
Presenters
Facebook Comments